Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000489298 | SCV000577843 | uncertain significance | not provided | 2024-02-22 | criteria provided, single submitter | clinical testing | Identified with a second variant in a patient with MCCC2-related 3-methylcrotonyl-CoA carboxylase 2 deficiency in published literature (PMID: 36822454); In silico analysis supports a deleterious effect on splicing; This variant is associated with the following publications: (PMID: 31901042, 31589614, 36822454) |
Labcorp Genetics |
RCV002527038 | SCV003520501 | uncertain significance | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2022-11-01 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 4 of the MCCC2 gene. It does not directly change the encoded amino acid sequence of the MCCC2 protein. This variant is present in population databases (rs770917710, gnomAD 0.03%). This variant has been observed in individual(s) with MCCC2-related conditions (PMID: 31901042). ClinVar contains an entry for this variant (Variation ID: 427200). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Baylor Genetics | RCV002527038 | SCV005060780 | likely pathogenic | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2024-03-28 | criteria provided, single submitter | clinical testing |